The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons
Abstract
Neuroleptic (antipsychotic) drugs inhibited the electrically stimulated release of [3 H]dopamine from rat striatal slices. The concentrations for 50 percent inhibition (ranging from 11.5 nanomolar for spiroperidol to 800 nanomolar for thioridazine) correlated closely with the average daily dosages of 25 neuroleptic drugs used clinically for schizophrenia. The correlation includes butyrophenones, phenothiazines, reserpine, pimozide, clozapine, and (+)-butaclamol. Clinically inactive isomers [trans-thiothixene,trans-flupenthixol, and (-)-butaclamol] required 20 to 1000 times higher concentrations than the active isomers to inhibit release. Compared to the inhibition of [3 H]dopamine release, much higher neuroleptic concentrations were needed to inhibit the electrically stimulated release of other neurotransmitters—[3 H]acetylcholine, [3 H]GABA (γ-aminobutyric acid). The neuroleptic drugs may block the presynaptic coupling between impulse and neurosecretion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The DA hypothesis of schizophrenia suggests that excess DA transmission may be pro-psychotic, and originally gained support from pharmacological evidence that drugs that decrease DA activity (for example,, the phenothiazine neuroleptics) are antipsychotic, whereas drugs that promote DA activity (for example,, amphetamines) are psychotomimetic [76,357].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [76]
In the citing paper
“the medications that have proven successful for treating schizophrenia/psychosis are drugs that primarily antagonize D2 receptors [76,358]”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [76]
Citations
Cites
The Membrane Actions of Anesthetics and Tranquilizers
Seeman, P. M. (1972) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06931-5 · Cited by 2,241
Self-citationCarlsson, A., & Lindqvist, M. (1963) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1963.tb01730.x · Cited by 2,156
DOPAMINERGIC NEURONS: EFFECT OF ANTIPSYCHOTIC DRUGS AND AMPHETAMINE ON SINGLE CELL ACTIVITY
Bunney, B. S., Walters, J. R., Roth, R. H., & Aghajanian, G. K. (1973) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29539-8 · Cited by 1,283
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics
Andén, N., Butcher, S. G., CORRODI, H., Fuxé, K., & Ungerstedt, U. (1970) · European Journal of Pharmacology · doi:10.1016/0014-2999(70)90006-3 · Cited by 1,026
Drugs, Neurotransmitters, and Schizophrenia
Snyder, S. H., Banerjee, S. P., Yamamura, H. I., & Greenberg, D. A. (1974) · Science · doi:10.1126/science.184.4143.1243 · Cited by 834
The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs.
Jm, V. R. (1966) · PubMed · Cited by 508
Clement‐Cormier, Y. C., Kebabian, J. W., Petzold, G. L., & Greengard, P. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.4.1113 · Cited by 452
Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity
Kehr, W., Carlsson, A., Lindqvist, M., Magnusson, T., & Atack, C. (1972) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1972.tb09104.x · Cited by 417
Janssen, P. A., Cj, N., & Schellekens, K. H. L. (1965) · PubMed · Cited by 348
Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?
Matthysse, S. (1973) · PubMed · Cited by 338
Membrane Stabilization by Drugs: Tranquilizers, Steroids, and Anesthetics
Seeman, P. M. (1966) · International review of neurobiology · doi:10.1016/s0074-7742(08)60138-5 · Cited by 236
Self-citationWalters, J. R., & Roth, R. H. (1974) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29968-2 · Cited by 211
Horn, A. S., & Snyder, S. H. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.10.2325 · Cited by 199
Andén, N. ‐., CORRODI, H., Fuxé, K., & Ungerstedt, U. (1971) · European Journal of Pharmacology · doi:10.1016/0014-2999(71)90173-7 · Cited by 142
The displacement of membrane calcium by a local anesthetic (chlorpromazine)
Kwant, W. O., & Seeman, P. M. (1969) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(69)90194-1 · Cited by 139
Self-citationThe membrane concentraton of a local anesthetic (Chlorpromazine)
Kwant, W. O., & Seeman, P. M. (1969) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(69)90167-9 · Cited by 129
Self-citationThe surface activity of tranquilizers
Seeman, P. M., & Bialy, H. S. (1963) · Biochemical Pharmacology · doi:10.1016/0006-2952(63)90093-5 · Cited by 126
Self-citationTHE DOPAMINE-RELEASING ACTIONS OF NEUROLEPTICS AND ETHANOL
Seeman, P. M., & Lee, T. (1974) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29902-5 · Cited by 109
Self-citationKarobath, M. E., & Leitich, H. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.7.2915 · Cited by 102
Dopamine receptor blockade — A central action of chlorpromazine on striatal neurones
York, D. H. (1972) · Brain Research · doi:10.1016/0006-8993(72)90348-4 · Cited by 92
Andén, N., CORRODI, H., & Fuxé, K. (1972) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1972.tb08961.x · Cited by 70
Lippmann, W., Pugsley, T. A., & Merker, J. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90019-3 · Cited by 59
Seeman, P. M., Staiman, A., & Chau-Wong, M. (1974) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29901-3 · Cited by 59
Self-citationMembrane expansion of the erythrocyte by both the neutral and ionized forms of chloropromazine
Seeman, P. M., & Kwant, W. O. (1969) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(69)90165-5 · Cited by 57
Self-citationBruderlein, F. T., Humber, L. G., & Voith, K. (1975) · Journal of Medicinal Chemistry · doi:10.1021/jm00236a016 · Cited by 47
Presynaptic Action of Central Depressant Drugs: Inhibition of Depolarization–Secretion Coupling
Quastel, D. M. J., Hackett, J. T., & Okamoto, K. (1972) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y72-042 · Cited by 44
Nyb�ck, H., & Sedvall, G. (1972) · Psychopharmacology · doi:10.1007/bf00422102 · Cited by 40
Miller, R. J., & Iversen, L. L. (1974) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1974.tb09243.x · Cited by 34
EFFECTS OF ETHANOL ON NOREPINEPHRINE UPTAKE AND ELECTRICALLY STIMULATED RELEASE IN BRAIN TISSUE*
Israel, Y., Carmichael, F. J., & Macdonald, J. A. (1973) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1973.tb28246.x · Cited by 33
Wallgren, H. (1963) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1963.tb05050.x · Cited by 25
Janssen, P. A., & Ft, A. (1969) · PubMed · Cited by 25
Effect of calcium, sodium and potassium on adrenal tyrosine hydroxylase activity in vitro
Gutman, Y., & Segal, J. (1972) · Biochemical Pharmacology · doi:10.1016/0006-2952(72)90239-0 · Cited by 22
Wirz‐Justice, A. (1972) · European Journal of Pharmacology · doi:10.1016/0014-2999(72)90021-0 · Cited by 8
Enhanced Binding of Chlorpromazine to Cholesterol-Depleted Synaptosome Fractions
Seeman, P. M., & Lee, T. (1974) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y74-069 · Cited by 7
Self-citationSUPPRESSION PAR LA SULPIRIDOTHERAPIE DES TROUBLES DE SEVRAGE DES CHIENS HEROINOMANES
Barre, J. L. (1974) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · Cited by 1
Flagged first, then by citations
Research works printed but not linked: 9
- Aghajanian, G. K., Frontiers in Neurology and Neuroscience Research: 4 (1974).
- FARNEBO, L. O., ACTA PHYSIOLOGICA SCANDINAVICA 371: 19 (1971).
- FARNEBO, L. O., ACTA PHYSIOLOGICA SCANDINAVICA 371: 35 (1971).
- Munkvad, I., The Neuroleptics. Modern Problems in Pharmacopsychiatrv 5: 44 (1970).
- RITCHIE, J.M., ON ACTIVE STRUCTURE OF LOCAL ANESTHETICS, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 133: 241 (1961).
- SEEMAN, P, FEDERATION PROCEEDINGS 33: 246 (1974).
- SOTELO, C, ULTRASTRUCTURAL IDENTIFICATION OF NIGRAL DOPAMINERGIC CELLS IN RAT, JOURNAL DE PHARMACOLOGIE 5: 55 (1974).
- STAWARZ, R.J., SIGNIFICANCE OF INCREASE OF HOMOVANILLIC-ACID (HVA) CAUSED BY ANTIPSYCHOTICS IN CORPUS STRIATUM AND LIMBIC FOREBRAIN, FEDERATION PROCEEDINGS 33: 246 (1974).
- ZIVKOVIC, B, SPECIFIC ACTIVATION OF STRIATAL TYROSINE-HYDROXYLASE (TH) BY NEUROLEPTICS, FEDERATION PROCEEDINGS 33: 536 (1974).
Cited by
Sorted by citations
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Antipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
Self-citationRegulation of noradrenaline release by presynaptic receptor systems
Starke, K. (1977) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/bfb0050157 · Cited by 1,469
SIXTH GADDUM MEMORIAL LECTURE NATIONAL INSTITUTE FOR MEDICAL RESEARCH, MILL HILL, JANUARY 1977
Langer, S. Z. (1977) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1977.tb07526.x · Cited by 938
Metadata
- Authors
- Seeman, P., & Lee, T.
- Affiliations
- University of Toronto (CA)
- ORCID
- Venue
- Science
- Published
- 1975-06-20
- Volume
- 188
- Issue
- 4194
- Pages
- 1217-1219
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2006122360
- Cited by
- 869
- References
- 35
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 13 · 2023: 16 · 2022: 22 · 2021: 13 · 2020: 18 · 2019: 36 · 2018: 21 · 2017: 30 · 2016: 26 · 2015: 28 · 2014: 37 · 2013: 23 · 2012: 32
- FWCI
- 62.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- antipsychotic drugs, presynaptic dopamine release, striatum, spiperone, thioridazine, butyrophenones, phenothiazines, reserpine, pimozide, clozapine, butaclamol, stereoisomers, acetylcholine release, GABA release, schizophrenia
- MeSH terms
- Acetylcholine, Animals, Corpus Striatum, Dopamine, Dose-Response Relationship, Drug, Electric Stimulation, gamma-Aminobutyric Acid, Haloperidol, Humans, Male, Neurons, Neurosecretion, Schizophrenia, Tranquilizing Agents, Tritium, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review